Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeStance Health (LFST) Income towards Parent Company (2020 - 2025)

LifeStance Health (LFST) has disclosed Income towards Parent Company for 6 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Income towards Parent Company rose 292.44% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Dec 2025, up 120.33% year-over-year, with the annual reading at $11.7 million for FY2025, 120.33% up from the prior year.
  • Income towards Parent Company for Q4 2025 was $13.7 million at LifeStance Health, up from $1.1 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $13.7 million in Q4 2025, with the low at -$120.5 million in Q3 2021.
  • Average Income towards Parent Company over 5 years is -$37.7 million, with a median of -$36.0 million recorded in 2022.
  • The sharpest move saw Income towards Parent Company plummeted 3556.71% in 2021, then skyrocketed 292.44% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$108.0 million in 2021, then skyrocketed by 56.81% to -$46.7 million in 2022, then grew by 3.64% to -$45.0 million in 2023, then surged by 84.18% to -$7.1 million in 2024, then surged by 292.44% to $13.7 million in 2025.
  • According to Business Quant data, Income towards Parent Company over the past three periods came in at $13.7 million, $1.1 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.